Schechter PJ - Search Results

1

Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects.

Séréni D, Tubiana R, Lascoux C, Katlama C, Taulera O, Bourque A, Cohen A, Dvorchik B, Martin RR, Tournerie C, Gouyette A, Schechter PJ. Séréni D, et al. Among authors: schechter pj. J Clin Pharmacol. 1999 Jan;39(1):47-54. doi: 10.1177/00912709922007552. J Clin Pharmacol. 1999. PMID: 9987700 Clinical Trial.

2

Pharmacokinetics of vigabatrin: implications of creatinine clearance.

Haegele KD, Huebert ND, Ebel M, Tell GP, Schechter PJ. Haegele KD, et al. Among authors: schechter pj. Clin Pharmacol Ther. 1988 Nov;44(5):558-65. doi: 10.1038/clpt.1988.194. Clin Pharmacol Ther. 1988. PMID: 3180638

3

Pharmacokinetics of piroximone (MDL 19.205) in healthy volunteers.

Haegele KD, Belz GG, Meinicke TT, Schechter PJ. Haegele KD, et al. Among authors: schechter pj. Eur J Clin Pharmacol. 1986;31(2):239-42. doi: 10.1007/BF00606667. Eur J Clin Pharmacol. 1986. PMID: 3803422

4

Pharmacokinetics of tacrolimus in liver transplant patients.

Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA. Jusko WJ, et al. Clin Pharmacol Ther. 1995 Mar;57(3):281-90. doi: 10.1016/0009-9236(95)90153-1. Clin Pharmacol Ther. 1995. PMID: 7535213 Clinical Trial.

5

Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonist.

Haegele KD, Jaillon P, Cheymol G, Alken RG, Schechter PJ, Koch-Weser J. Haegele KD, et al. Among authors: schechter pj. Clin Pharmacol Ther. 1983 Dec;34(6):785-91. doi: 10.1038/clpt.1983.250. Clin Pharmacol Ther. 1983. PMID: 6641094

6

Clinical pharmacology of vigabatrin.

Schechter PJ. Schechter PJ. Br J Clin Pharmacol. 1989;27 Suppl 1(Suppl 1):19S-22S. doi: 10.1111/j.1365-2125.1989.tb03456.x. Br J Clin Pharmacol. 1989. PMID: 2667604 Free PMC article. Review.

7

Kinetics of fenoximone, a new cardiotonic, in healthy subjects.

Alken RG, Belz GG, Haegele KD, Meinicke T, Schechter PJ. Alken RG, et al. Among authors: schechter pj. Clin Pharmacol Ther. 1984 Aug;36(2):209-16. doi: 10.1038/clpt.1984.164. Clin Pharmacol Ther. 1984. PMID: 6235081

8

Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.

Galbraith WM, Hobson WC, Giclas PC, Schechter PJ, Agrawal S. Galbraith WM, et al. Among authors: schechter pj. Antisense Res Dev. 1994 Fall;4(3):201-6. doi: 10.1089/ard.1994.4.201. Antisense Res Dev. 1994. PMID: 7849490

9

Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.

Haegele KD, Schechter PJ. Haegele KD, et al. Among authors: schechter pj. Clin Pharmacol Ther. 1986 Nov;40(5):581-6. doi: 10.1038/clpt.1986.227. Clin Pharmacol Ther. 1986. PMID: 3769388

10

Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase.

Haegele KD, Alken RG, Grove J, Schechter PJ, Koch-Weser J. Haegele KD, et al. Among authors: schechter pj. Clin Pharmacol Ther. 1981 Aug;30(2):210-7. doi: 10.1038/clpt.1981.150. Clin Pharmacol Ther. 1981. PMID: 6788425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters